Alan Menter, MD, Chair, Alice Gottlieb, MD, PhD, Steven R

Slides:

Advertisements

Similar presentations

Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment Juul M.P.A.

Advertisements

Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients Lily Chen, BA, Feng Gao, MD, PhD, MPH,

Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors

Yul W. Yang, MD, PhD, David J. DiCaudo, MD

Daniel S. Winchester, MD, Thomas L. Hocker, MD, Randall K. Roenigk, MD

OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results Alexa B. Kimball,

Image registration of sequential transparent photographs to localize and detect new versus recurrent tumors in dermatologic and Mohs micrographic surgery

Efficacy of simvastatin in plaque psoriasis: A pilot study

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD

Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis Federica Ricceri, MD, Leonardo.

Surveillance and assessment of occupational dermatitis using Rhode Island workers' compensation data 1998 to 2002 Irwin B. Horwitz, PhD, Brian P. McCall,

Vaishali Patel, PharmD, Elizabeth J. Horn, PhD, Steve J

Photo-induced Stevens-Johnson syndrome

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study Hsien-Yi Chiu, MD, Tsen-Fang.

Pediatric teledermatology: Observations based on 429 consults

Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment Juul M.P.A.

Brad A. Yentzer, MD, Ali Alikhan, BS, Hoa Teuschler, MS, Lisa L

Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD

David T. Pompei, Pharm D, Kameron S. Rezzadeh, BS, Kate V

Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors

Katherine E. Brick, BS, Robert H. Cook-Norris, MD, David A

Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry David Fiorentino, MD, PhD, Vincent Ho, MD, Mark.

The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis Alan Menter, MD, Jennifer C. Cather, MD, Diane.

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled.

Parul Kathuria, BA, Kenneth B. Gordon, MD, Jonathan I

Pharmacy costs of specialty medications for plaque psoriasis in the United States Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

Smoking and risk of psoriasis: A nationwide cohort study

A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis Lorinda Chung, MD, David Fiorentino,

Effect of psoriatic arthritis on ixekizumab clinical outcomes in moderate-to-severe psoriasis patients: A post hoc analysis Alice B. Gottlieb, MD, PhD,

Methotrexate treatment in patients with a history of cutaneous melanoma and the risk of a consecutive primary melanoma: A national retrospective registry-based.

Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection Alberto Conde-Taboada, MD, Javier Pedraz Muñoz, MD, Lucía.

Relapsing polychondritis-like ear disease responding to etanercept in two patients with psoriasis and psoriatic arthritis Hsing-Chuan Lee, MD, Tsen-Fang.

Characterization of disease burden, comorbidities, and treatment use in a large, US- based cohort: Results from the Corrona Psoriasis Registry Bruce Strober,

Plasma β-endorphin levels in frequent and infrequent tanners before and after ultraviolet and non-ultraviolet stimuli Mandeep Kaur, MD, Anthony Liguori,

Seasonal variation of acne and psoriasis: A 3-year study using the Physician Global Assessment severity scale Vanessa Lindsay Pascoe, MD, Alexandra Boer.

Severe hypoglycemia after initiation of anti–tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2.

Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis Eric Sorenson, AB, Ethan Levin, MD, John Koo, MD, Timothy.

A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening Dayoung Ko, BS, Shari R. Lipner, MD, PhD

Volume 4, Issue 8, Pages (September 2018)

Loss of efficacy of secukinumab for psoriasis at 24 to 32 weeks

Infectious rash after riding elephants

Lip edema Journal of the American Academy of Dermatology

Eva Wang, BS, John Koo, MD, Elie Levy, MD

Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions Herbert C. Chiang, MD,

Leflunomide as adjuvant treatment of dermatomyositis

Granulocyte and monocyte adsorption apheresis for leg ulcers in a patient with rheumatoid arthritis Takuro Kanekura, MD, PhD, Yuji Mochitomi, MD, Shizuyo.

Volume 5, Issue 2, Pages (February 2019)

Appearance of lentigines in psoriasis patients treated with apremilast

Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3.

Guidelines of care for the management of psoriasis and psoriatic arthritis Alan Menter, MD, Neil J. Korman, MD, PhD, Craig A. Elmets, MD, Steven R. Feldman,

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities Craig A. Elmets, MD, Craig.

Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1,

Modification of the nail psoriasis severity index

Tofacitinib therapy for children with severe alopecia areata

Alice Gottlieb, MD, PhD, Neil J. Korman, MD, PhD, Kenneth B

Derek Y. Hsu, BA, Kenneth Gordon, MD, Jonathan I

Jose Fernández-Vozmediano, PhD, Jose Armario-Hita, MD

Michelle A. Pipitone, MD, Brian Adams, MD, MPH, Anita Sheth, MD, T

Etanercept therapy in two patients with psoriasis and concomitant hepatitis C Clara De Simone, MD, Andrea Paradisi, MD, Rodolfo Capizzi, MD, Angelo Carbone,

Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation Suelen Montagner, MD, Francisco Aparecido.

A simple algorithm for evaluating dermatologic disease in critically ill patients: A study based on retrospective review of medical intensive care unit.

A grayscale photograph with high dynamic range taken under a Wood's lamp for better recognition of vitiligo lesions Jung Min Bae, MD, PhD, Tae Young.

Alan Menter, MD, Stephen K

Numerous hyperpigmented macules of the oral mucosa

April W. Armstrong, MD, MPH, Michael P

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

Stuart M. Goldsmith, MD, Armand B. Cognetta, MD

Brodalumab in the treatment of moderate to severe psoriasis in patients when previous anti-interleukin 17A therapies have failed Grace Kimmel, MD, Margot.

Presentation transcript:

Guidelines of care for the management of psoriasis and psoriatic arthritis Alan Menter, MD, Chair, Alice Gottlieb, MD, PhD, Steven R. Feldman, MD, PhD, Abby S. Van Voorhees, MD, Craig L. Leonardi, MD, Kenneth B. Gordon, MD, Mark Lebwohl, MD, John Y.M. Koo, MD, Craig A. Elmets, MD, Neil J. Korman, MD, PhD, Karl R. Beutner, MD, PhD, Reva Bhushan, PhD Journal of the American Academy of Dermatology Volume 58, Issue 5, Pages 826-850 (May 2008) DOI: 10.1016/j.jaad.2008.02.039 Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Photographs of patients with psoriasis. A, Small plaque psoriasis. B, Localized thick plaque type psoriasis. C, Large plaque psoriasis. D, Inflammatory localized psoriasis. E, Erythrodermic psoriasis. F, Psoriasis and psoriatic arthritis. Journal of the American Academy of Dermatology 2008 58, 826-850DOI: (10.1016/j.jaad.2008.02.039) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

Fig 2 Photographs of patients with psoriasis. A, Thin plaque type psoriasis. B, Inverse type psoriasis. C, Pustular type psoriasis. D, Guttate type psoriasis. Journal of the American Academy of Dermatology 2008 58, 826-850DOI: (10.1016/j.jaad.2008.02.039) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

Fig 3 Photographs of patients with nail psoriasis. Journal of the American Academy of Dermatology 2008 58, 826-850DOI: (10.1016/j.jaad.2008.02.039) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

Fig 4 Decision tree. ∗Patients with nondeforming psoriatic arthritis without any radiographic changes, loss of range of motion, or interference with tasks of daily living should not automatically be treated with tumor necrosis factor (TNF) inhibitors. It would be reasonable to treat these patients with nonsteroidal anti-inflammatory agent or to consult rheumatologist for therapeutic options. †Patients with limited skin disease should not automatically be treated with systemic treatment if they do not improve, because treatment with systemic therapy may carry more risk than the disease itself. MTX, Methotrexate; PUVA; psoralen plus ultraviolet (UV)-A. Journal of the American Academy of Dermatology 2008 58, 826-850DOI: (10.1016/j.jaad.2008.02.039) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions